
Quantum promotes senior head
pharmafile | October 29, 2014 | Appointment | Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Alison Doering, quantam pharmaceutical
Alison Doering has been promoted to head of group marketing and communications at medicines manufacturing firm Quantum Pharmaceutical.
Doering will report to group commercial director Brian Fisher and joins Quantum’s senior management team from Protomed, which is an existing business within the group.
Doering will lead all brand and corporate marketing and communications for all businesses within Quantum including UL Medicines, Protomed and Biodose Services.
Fisher says: “Alison was instrumental in improving the visibility of the Biodose medicines delivery system in her previous role. I am delighted that we were able to promote her from within the organisation to this senior role.”






